Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 57951-58000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06333145
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
PHASE4Recruiting
165 participants
Started: Feb 4, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06169579
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
PHASE1Enrolling by invitation
96 participants
Started: Feb 4, 2024 · Completed: Jun 30, 2026
1 condition3 sponsors21 locations
NCT06271213
The Gut-Lung Axis and Respiratory Illness in Children
N/ARecruiting
150 participants
Started: Feb 4, 2024 · Completed: May 1, 2028
6 conditions2 sponsors1 location
NCT06893419
Geriatric Telemanagement of HEALTH Conditions in Nursing Home Residents Recently Discharged From the Hospital- GET HEALTH-I
NARecruiting
102 participants
Started: Feb 4, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06323681
Pegylated Interferon α in Previously Interferon-treated CHB(Leading Study)
NARecruiting
2,016 participants
Started: Feb 4, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06515743
Rehabilitation With an Obturator in Maxillary Defects
N/AActive, not recruiting
60 participants
Started: Feb 4, 2024 · Completed: Nov 30, 2024
1 condition2 sponsors1 location
NCT05513716
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
N/ARecruiting
200 participants
Started: Feb 4, 2024 · Completed: Jul 3, 2025
1 condition2 sponsors1 location
NCT06086457
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
PHASE3Recruiting
436 participants
Started: Feb 4, 2024 · Completed: Aug 28, 2029
1 condition17 sponsors1 location
NCT05364788
Molecular Characterisation of Appendiceal Cancer
N/ARecruiting
100 participants
Started: Feb 4, 2024 · Completed: Jul 3, 2025
1 condition2 sponsors1 location
NCT06797414
Comparison of Pilate Exercises With and Without Whole Body Vibration in Patient With Upper Cross Syndrome
NARecruiting
56 participants
Started: Feb 4, 2024 · Completed: Feb 7, 2025
1 condition1 sponsor1 location
NCT06231368
CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.
PHASE1Active, not recruiting
6 participants
Started: Feb 4, 2024 · Completed: Aug 31, 2025
3 conditions2 sponsors1 location
NCT06299800
Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer
N/ARecruiting
779 participants
Started: Feb 4, 2024 · Completed: Feb 4, 2025
2 conditions1 sponsor1 location
NCT05968157
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NARecruiting
200 participants
Started: Feb 4, 2024 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT06243354
Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation
PHASE1/PHASE2Recruiting
257 participants
Started: Feb 4, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor6 locations
NCT06732765
Comparative Effects of Eloda With/Without Muscle Energy Technique in Patient With Quadratus Lumborum Syndrome
NARecruiting
62 participants
Started: Feb 4, 2024 · Completed: Jan 15, 2025
1 condition1 sponsor1 location
NCT06185933
Lidocaine Spray vs Viscous Lidocaine Solution Plus Lidocaine Spray in Patients Undergoing Non-Sedated EGD
NAEnrolling by invitation
250 participants
Started: Feb 4, 2024 · Completed: Oct 30, 2024
2 conditions1 sponsor1 location
NCT06340165
A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer
N/ARecruiting
153 participants
Started: Feb 4, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06273137
Positive Affect Treatment for Adolescents with Early Life Adversity
NARecruiting
300 participants
Started: Feb 3, 2024 · Completed: Oct 31, 2030
1 condition1 sponsor1 location
NCT06241469
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction,a Phase II Clinical Study
PHASE2Not yet recruiting
40 participants
Started: Feb 3, 2024 · Completed: Feb 2, 2027
3 conditions1 sponsor1 location
NCT05865561
Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures
N/ARecruiting
100 participants
Started: Feb 3, 2024 · Completed: Oct 3, 2025
1 condition1 sponsor1 location
NCT05487053
The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement
NARecruiting
220 participants
Started: Feb 3, 2024 · Completed: Jul 1, 2028
2 conditions1 sponsor1 location
NCT06329999
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
NARecruiting
78 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2027
3 conditions18 sponsors1 location
NCT06360718
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
NARecruiting
140 participants
Started: Feb 3, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT07100535
Education and Literacy for an Active Life (Educação e Literacia Para Uma Vida Ativa)
NAActive, not recruiting
128 participants
Started: Feb 3, 2024 · Completed: May 31, 2029
6 conditions2 sponsors1 location
NCT06303128
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
PHASE3Recruiting
380 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06225648
Threonine Requirement in Adults >60 Years of Age
NARecruiting
40 participants
Started: Feb 3, 2024 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06816186
The Impact of Multimedia Childbirth Prediction on Parturients and Their Spouses
NARecruiting
190 participants
Started: Feb 3, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05912647
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
NARecruiting
376 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06206317
Comparison of Motor and Sensory Functions of the Hand in Children With Type 1 Diabetes Mellitus and Their Healthy Peers
N/ANot yet recruiting
140 participants
Started: Feb 3, 2024 · Completed: Jun 3, 2024
1 condition1 sponsor0 locations
NCT06216236
Effects of Physical Fitness Using a Kinect Interventional System
NARecruiting
60 participants
Started: Feb 3, 2024 · Completed: Oct 30, 2024
2 conditions3 sponsors2 locations
NCT06560086
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2
NARecruiting
10 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05331534
Effect of Attentional Therapy on Post-traumatic Stress Disorder
NARecruiting
140 participants
Started: Feb 2, 2024 · Completed: Feb 2, 2029
1 condition1 sponsor1 location
NCT06246721
Attitude and Success Rate of Women with Pelvic Organ Prolapse on Self-management of Vaginal Pessary
NARecruiting
289 participants
Started: Feb 2, 2024 · Completed: Dec 15, 2025
1 condition2 sponsors1 location
NCT06256224
Toripalimab Combined With Definitive CCRT for LACC Patients
NARecruiting
150 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06060938
Personalized Breast Cancer Screening
NAActive, not recruiting
2,200 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2034
1 condition5 sponsors1 location
NCT06563869
Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
PHASE3Recruiting
40 participants
Started: Feb 2, 2024 · Completed: Nov 22, 2026
1 condition1 sponsor1 location
NCT06337097
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
NARecruiting
880 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05968391
Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)
N/ARecruiting
15 participants
Started: Feb 2, 2024 · Completed: Jun 15, 2025
1 condition2 sponsors1 location
NCT06092463
The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease
N/ARecruiting
275 participants
Started: Feb 2, 2024 · Completed: Oct 30, 2029
5 conditions3 sponsors2 locations
NCT06251037
"Youth Aware of Mental Health in Galicia"
NAEnrolling by invitation
4,453 participants
Started: Feb 2, 2024 · Completed: Jun 15, 2025
7 conditions1 sponsor68 locations
NCT06671886
NAFLD Clinical Care Pathway
NARecruiting
32 participants
Started: Feb 2, 2024 · Completed: Nov 13, 2028
2 conditions1 sponsor1 location
NCT05888428
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss
NARecruiting
16 participants
Started: Feb 2, 2024 · Completed: Jan 31, 2026
2 conditions4 sponsors1 location
NCT05207085
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
PHASE2Recruiting
20 participants
Started: Feb 2, 2024 · Completed: Oct 15, 2026
1 condition2 sponsors1 location
NCT06062342
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
NARecruiting
20,400 participants
Started: Feb 2, 2024 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT06220838
Study SC-101 in Subjects With Advanced Malignancies
PHASE1Recruiting
100 participants
Started: Feb 2, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor5 locations
NCT05962606
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
PHASE2Recruiting
150 participants
Started: Feb 2, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor28 locations
NCT06252545
Promoting CT Engagement for Pancreatic Cancer With App
NARecruiting
26 participants
Started: Feb 2, 2024 · Completed: Feb 1, 2027
1 condition2 sponsors2 locations
NCT05421065
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
PHASE2Active, not recruiting
20 participants
Started: Feb 2, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06257017
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma
PHASE2Recruiting
20 participants
Started: Feb 2, 2024 · Completed: Dec 30, 2025
2 conditions3 sponsors1 location
NCT06035445
Support for Adolescents Living With HIV in South Africa
NARecruiting
1,000 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2027
2 conditions3 sponsors1 location